Affiliation: University of Basel
The Swiss Tropical and Public Health Institute (Swiss TPH), former Swiss Tropical Institute (STI), has been founded in 1943. It has research and teaching activities in the arear of international health development. In June 2009 the Institute for Social and Preventive Medicine of the University of Basel, active in the areas of environmental epidemiology and women’s health, was integrated into the Swiss TPH.
Today over 500 employees from 40 nations work worldwide for the Swiss TPH in research, teaching and services with the main goal to contribute to health development worldwide.
As an associate institute of the University of Basel, the Swiss TPH takes part in teaching within various faculties, as well as is engaged in post-graduate education and advanced training on national and international levels.
The Swiss TPH receives 81% of its income through competitive fundraising and the earnings of our service departments. The remaining budget is given by the Basel cantons and the Swiss federal government.
Non-Communicable Diseases (NCDs) such as diabetes and high blood pressure are the number one cause of death and disability globally. More than 75% of premature NCD-related deaths occur in lowand middle-income countries. A new programme coordinated by SolidarMed, Swiss TPH and partners in Lesotho aims to tackle NCDs in Lesotho, building on long-term experience in HIV/AIDS chronic disease care.
Population mobility is a result of globalisation that will likely continue to increase exponentially. EXPAND, a new project led by Swiss TPH, aims to expand neglected tropical diseases and COVID-19 surveillance and control to mobile pastoralists in Chad by increasing access to health information and services, and promoting integrated interventions. Facilitating access for this population ensures that "no one is left behind" - a prerequisite for disease elimination and the achievement of universal health coverage.
Strong and resilient supply chains ensure the provision of quality health products and vaccines to patients, making them a central component of health systems. At the virtual Swiss TPH Winter Symposium that took place on 1 December, experts from academia, public administration, international organisations and the private sector came together to discuss how we can achieve universal access to high quality, affordable medicines and vaccines.
Iron-deficiency anaemia is a major concern in low-income settings, especially for women. In a new study by the Swiss Tropical and Public Health Institute (Swiss TPH) and partners published yesterday in The Lancet Global Health, researchers found that iron infusion was feasible, safe and in contrast to the standard iron-deficiency anaemia treatment of oral iron tablets, highly effective in Tanzania. This is the first study to provide evidence of the benefits and safety of iron infusion in a low-income setting.
Pascale Vonaesch, Scientific Project Leader at the Swiss Tropical and Public Health Institute (Swiss TPH), was awarded a prestigious Eccellenza Professorial Fellowship grant of the Swiss National Science Foundation (SNSF). The grant will allow Vonaesch to pursue her research in childhood nutrition and health.
The Swiss Federal Department of Economic Affairs, Education and Research increases its core contribution to the Swiss Tropical and Public Health Institute (Swiss TPH) from CHF 6.25 million to CHF 8 million per year. Together with the additional funding from the two Basel cantons, the contribution over the next strategy period of 2021-2024 will support the work of Swiss TPH in improving public and global health through excellence in research, education and services.
The coronavirus is not only a risk for our physical health, but also affects our mental health and emotional well-being. Today is the "Day of Action" in Switzerland, which is designed to support people's mental well-being in times of COVID-19. Nicole Probst-Hensch from the Department of Epidemiology and Public Health at Swiss TPH talks about how research can contribute, and what she does to maintain her own mental well-being.
Tobias Schindler has received the R. Geigy Award 2020 worth CHF 20,000 in recognition of his achievements in the development of new diagnostic tools in the fight against diseases such as malaria and the COVID-19 pandemic in Africa. In memory of the biologist and founder of Swiss TPH, Rudolf Geigy, the R. Geigy Foundation presents this award every two years to young researchers who have distinguished themselves through outstanding achievements in the field of neglected tropical diseases or public health.
African countries and an international network of research institutions, including the Swiss Tropical and Public Health Institute (Swiss TPH), have joined forces to launch the largest COVID-19 clinical trial in mild-to-moderate outpatients in Africa. The ANTICOV clinical trial aims to respond to the urgent need to identify treatments that can be used to treat mild and moderate cases of COVID-19 early and prevent spikes in hospitalisation that could overwhelm fragile and already overburdened health systems in Africa.
TIGER is an project between France, Germany and Switzerland to support the cross-border monitoring and control of the Asian tiger mosquito in the Upper Rhine region. On 13 November, Swiss TPH hosted a one-day virtual symposium, where the project team, consisting of Swiss TPH and partners, presented on the current situation of the spread of the tiger mosquito in the region, as well as the project results from the past three years.